Matters of legal in nature including licensing, intellectual property, and lawsuits.
Company’s Work with Federal organization focused on heavy metals and cannabinoid analysis aimed at helping labs and producers meet key regulations more effectively and efficiently October 19, 2021 WHAT : PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced its participation in the National Institute of Standards and Technology’s (NIST)... Read more
Leader in Next-Generation Sequencing Workflow Automation Gains Agency Accreditation for Animal Health Testing SAN CARLOS, CALIF. (PRWEB) OCTOBER 14, 2021 Today, Clear Labs, a leader in providing fully automated, next-generation sequencing (NGS) platforms for turnkey diagnostics, is announcing that Clear Safety Salmonella has been approved by the National Poultry Improvement Plan (NPIP) for interim use in the detection of... Read more
SANTA CLARA, Calif., October 13, 2021 Agilent Technologies Inc. (NYSE: A) today announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early breast cancer (EBC) at high risk of disease recurrence, for whom adjuvant treatment with Verzenio® (abemaciclib) in combination with endocrine therapy is being considered.... Read more
35% reduction in risk of needing a walking aid in relapsing multiple sclerosis (RMS) after 7.5 years vs. initiation 2 years later in Phase III open-label extension (OLE) 29% reduction in 48-week confirmed disability progression in primary progressive MS (PPMS) after 8 years vs. initiation after double-blind period in Phase III OLE New 8-year safety... Read more
Scientists are rushing to study the tiny plastic particles that are in marine animals — and in us. The distribution of microplastics into the world is extensive; however, the implications of microplastics are not yet thoroughly understood. Dr. Elke Fischer from the Department of Earth Sciences of the University of Hamburg is providing compelling insights... Read more
OCREVUS (ocrelizumab) data to show sustained reduction in disability progression through 8 years for primary progressive multiple sclerosis (PPMS) and 7.5 years for relapsing MS (RMS) Long-term safety analysis of all clinical trials will reinforce the consistently favourable benefit-risk profile of OCREVUS ENSPRYNG (satralizumab) data to show efficacy and safety sustained over four years of... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Oct. 4, 2021– Leading global water technology company, Xylem Inc., and Dragos, Inc., the global leader in cybersecurity for industrial controls systems (ICS)/operational technology (OT) environments, today announced they have partnered to bring best-in-class industrial cybersecurity to critical infrastructure in the water sector. The agreement will see Xylem and Dragos offering co-branded... Read more
Provides Long-term Financial Framework and Updates Current Year Outlook RYE BROOK, NY–(BUSINESS WIRE)–Sep. 30, 2021– Global water technology company, Xylem (NYSE:XYL), will reaffirm its growth strategy and set out its long-term financial framework at its Investor Day, to be held today. Xylem President and CEO Patrick Decker, along with other senior leaders, will provide an... Read more
PROVEN BISULFITE TECHNOLOGY IDEAL FOR CLINICAL APPLICATIONS IRVINE, Calif., (September 22, 2021) — Today Zymo Research announced its EZ DNA Methylation-Lightning Kit has received the CE IVD Mark allowing the technology to be distributed within the European Union (EU) common market. Chemical treatment of DNA with bisulfite is the prerequisite for many methylation-based diagnostic assays. Clinical diagnostic and... Read more